NCT03594370View on ClinicalTrials.gov

Multiple Noninvasive Examination Modality to Evaluate the Severity of Ocular Surface Disorders

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

June 8, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

May 22, 2019

Conditions
Limbal Stem-cell Deficiency
Trial Locations (1)

Unknown

NTUH, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT03594370 - Multiple Noninvasive Examination Modality to Evaluate the Severity of Ocular Surface Disorders | Biotech Hunter | Biotech Hunter